Emergent biosolutions earnings call
WebAug 1, 2024 · Emergent BioSolutions Market Cap $491M Today's Change (0.92%) $0.09 Current Price $9.88 Price as of April 4, 2024, 10:00 a.m. ET EBS earnings call for the … WebApr 10, 2024 · -- Le azioni di Emergent Biosolutions sono aumentate di oltre il 12% nelle contrattazioni di lunedì, dopo che Benchmark ha aggiornato il titolo del produttore di farmaci a buy da hold con un... 11 aprile 2024 ... Transcript : Emergent BioSolutions Inc., Q4 2024 Earnings Call, Feb 27, 2024: CI. 27/02: Emergent BioSolutions Inc. riporta i ...
Emergent biosolutions earnings call
Did you know?
WebApr 10, 2024 · Emergent BioSolutions ( NYSE:EBS - Get Rating) last posted its quarterly earnings results on Monday, February 27th. The biopharmaceutical company reported ($0.31) EPS for the quarter, missing the consensus estimate of $0.31 by ($0.62). The business had revenue of $330.70 million during the quarter, compared to analyst … WebApr 6, 2024 · EBS Emergent BioSolutions Inc.Earnings Call Transcripts. 10.31K followers. $10.56 0.29 ( +2.82%) 4:00 PM 04/06/23. NYSE $USD Market Close. …
WebApr 10, 2024 · Transcript : Emergent BioSolutions Inc., Q4 2024 Earnings Call, Feb 27, 2024: CI. ... Recommandations des analystes sur EMERGENT BIOSOLUTIONS INC. 10/04: Emergent BioSolutions Inc. : Benchmark ... WebJul 29, 2024 · Emergent Biosolutions, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $397.5 million for the quarter ended June 2024, missing the Zacks Consensus...
WebApr 10, 2024 · Health-care companies fell as traders hedged their bets on the sector's earnings prospects. Emergent BioSolutions shares surged after analysts at brokerage Benchmark boosted their rating on the maker of overdose antidote Narcan, saying the stock price still didn't reflect the growth implications of the Food and Drug Administration's … WebResearch tools you need to invest in the public markets. We make listening to earnings calls easy.
WebFeb 20, 2024 · This biopharmaceutical company is expected to post quarterly earnings of $0.32 per share in its upcoming report, which represents a year-over-year change of -92.9%. Revenues are expected to be...
WebApr 30, 2024 · Image source: The Motley Fool. See All Market Activity. News + Insights bio-budget technologies gmbhWebAug 1, 2024 · Emergent Biosolutions , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $242.7 million for the quarter ended June 2024, missing the Zacks Consensus... da form 368 army pubsWebIndeed Featured review. Worked at Emergent for about 8 months. Pros: Plenty of overtime is available if you are cool with your supervisor (s) Con: Trash work-life balance, will drag … da form 4037 explainedWebFeb 27, 2024 · Emergent BioSolutions (NYSE: EBS) Q4 2024 Earnings Call Feb 27, 2024, 5:00 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good day,... da form 4187 pdf downloadWebApr 9, 2024 · Shares of EBS stock opened at $10.56 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.70 and a current ratio of 0.98. Emergent … da form 4702 trainingWebFeb 27, 2024 · We ended the fourth quarter with $643 million in cash as we took down the remaining approximately $360 million of available revolver capacity to further … da form 3975 military police reportWebQ4 2024 Emergent BioSolutions Inc Earnings Call. Thomson Reuters StreetEvents. Feb-27-23 10:00PM: Emergent BioSolutions (EBS) Q4 2024 Earnings Call Transcript. Motley Fool. 06:55PM: Emergent Biosolutions (EBS) Reports Q4 Loss, Tops Revenue Estimates. Zacks. 04:42PM: da form 3355 instructions